This Australian systematic review challenges current prescribing practices for cannabis in mental health conditions, where evidence quality has long been questioned. It forces clinicians to reconcile patient reports of benefit with rigorous trial data showing limited efficacy.
An Australian systematic review examined cannabis efficacy for mental health conditions and concluded limited therapeutic benefit. The review likely assessed randomized controlled trials across conditions like anxiety, depression, and PTSD, finding insufficient evidence to support cannabis as a mental health treatment. This adds to a growing body of literature questioning the evidence base for psychiatric cannabis prescribing, despite widespread patient use and anecdotal reports.
โI see this disconnect daily – patients reporting genuine relief while our best studies show modest effects at best. The real clinical challenge isn’t dismissing cannabis entirely, but helping patients understand what we actually know versus what we hope might be true.โ
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ
Have thoughts on this? Share it:
FAQ
This News item was assembled from structured source metadata and pipeline scoring.